Dermatologist highlights emerging technology for skin laxity treatment.
A Ketchum, Idaho dermatologist has publicly endorsed a new tool for treating sagging skin, signaling growing practitioner adoption of emerging skin-laxity technologies. While the specific device name is not disclosed in the report, the endorsement reflects ongoing market momentum in non-invasive and minimally invasive skin tightening.
The skin-laxity category has expanded significantly over the past 18 months, with FDA clearances for Ultherapy PRIME (real-time imaging for midface and now knee), Sofwave (ultrasonic microbubble), and XERF (fractional RF) all competing for market share. Practitioners are increasingly layering these modalities with injectables and energy devices to address the full spectrum of aging—a shift that has elevated skin tightening from a niche offering to a core revenue driver.
Skin-laxity treatment adoption accelerates among independent practitioners.
For practice owners, the takeaway is clear: skin laxity is no longer a referral-out diagnosis. Building competency in at least one tightening modality—whether ultrasound, RF, or radiofrequency microneedling—is becoming table-stakes for competitive positioning.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/mo
Join the owners who run ahead of the industry. Cancel anytime, one click.
